135 related articles for article (PubMed ID: 1970256)
1. CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms.
Orholm M; Nielsen TL; Nielsen JO; Lundgren JD
AIDS; 1990 Feb; 4(2):163-6. PubMed ID: 1970256
[TBL] [Abstract][Full Text] [Related]
2. Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy.
Böttiger B; Morfeldt-Månson L; Putkonen P; Nilsson B; Julander I; Biberfeld G
Scand J Infect Dis; 1989; 21(5):507-14. PubMed ID: 2511625
[TBL] [Abstract][Full Text] [Related]
3. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
4. Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children.
Arditi M; Kabat W; Yogev R
Pediatr Infect Dis J; 1991 Jun; 10(6):450-5. PubMed ID: 1677177
[TBL] [Abstract][Full Text] [Related]
5. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.
Masur H; Ognibene FP; Yarchoan R; Shelhamer JH; Baird BF; Travis W; Suffredini AF; Deyton L; Kovacs JA; Falloon J
Ann Intern Med; 1989 Aug; 111(3):223-31. PubMed ID: 2546472
[TBL] [Abstract][Full Text] [Related]
6. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.
Mulder JW; Krijnen P; Goudsmit J; Schattenkerk JK; Reiss P; Lange JM
Genitourin Med; 1990 Jun; 66(3):138-41. PubMed ID: 2115018
[TBL] [Abstract][Full Text] [Related]
8. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
[TBL] [Abstract][Full Text] [Related]
9. Donor HIV-1 p24 antigenaemia and course of infection in recipients Transfusion Safety Study Group.
Busch MP; Donegan E; Stuart M; Mosley JW
Lancet; 1990 Jun; 335(8701):1342. PubMed ID: 1971398
[No Abstract] [Full Text] [Related]
10. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
Mulder JW; de Wolf F; Goudsmit J; Cload PA; Coutinho RA; Fiddian AP; Schellekens PT; van der Noordaa J; Lange JM
Antiviral Res; 1990 Mar; 13(3):127-38. PubMed ID: 1972321
[TBL] [Abstract][Full Text] [Related]
11. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
[TBL] [Abstract][Full Text] [Related]
12. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
13. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
14. Surrogate markers for AIDS treatment.
Jacobson M
Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
[No Abstract] [Full Text] [Related]
15. Correlation of serum antigen and antibody concentration with clinical features in HIV infection.
Ellaurie M; Rubinstein A
Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767
[TBL] [Abstract][Full Text] [Related]
16. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.
Nishanian P; Huskins KR; Stehn S; Detels R; Fahey JL
J Infect Dis; 1990 Jul; 162(1):21-8. PubMed ID: 2113075
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
Lane HC; Davey V; Kovacs JA; Feinberg J; Metcalf JA; Herpin B; Walker R; Deyton L; Davey RT; Falloon J
Ann Intern Med; 1990 Jun; 112(11):805-11. PubMed ID: 1971503
[TBL] [Abstract][Full Text] [Related]
19. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
[TBL] [Abstract][Full Text] [Related]
20. Sensitive one-step enzyme immunoassay for HIV-1 p24 antigen in human blood specimens and cell culture supernatants.
Kontio S
J Immunol Methods; 1991 Jun; 139(2):257-63. PubMed ID: 1904466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
